Litcius/Paper detail

Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study

Elena María Rincón‐López, María Luisa Navarro Gómez, Teresa Hernández‐Sampelayo, David Aguilera‐Alonso, Eva Dueñas Moreno, Jesús Saavedra‐Lozano, Begoña Santiago García, Mar Santos, M Morin, Cristina Beléndez, Jorge Lorente Romero, Elena Cela de Julián, F-DREP Study Group, Alicia Hernanz‐Lobo, Carmen Garrido Colino, Jorge Huerta‐Aragonés, Cristina Mata Fernández, Eduardo Bardón Cancho, C. Míguez Navarro, Andrea Mora Capín, R. Marañón Pardillo, Arístides Rivas García, P. Vázquez López, Jose Luis Jiménez Fuentes, María Ángeles Muñoz‐Fernández, R. Arranz

2021BMC Infectious Diseases15 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Etiological diagnosis of fever in children with sickle cell disease (SCD) is often challenging. The aim of this study was to analyze the pattern of inflammatory biomarkers in SCD febrile children and controls, in order to determine predictors of severe bacterial infection (SBI). METHODS: A prospective, case-control study was carried out during 3 years, including patients younger than 18 years with SCD and fever (cases) and asymptomatic steady-state SCD children (controls). Clinical characteristics and laboratory parameters, including 10 serum proinflammatory cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-17a, IFN-γ and TNF-α) and comparisons among study subgroups were analyzed. RESULTS: A total of 137 patients (79 cases and 58 controls) were included in the study; 78.5% males, median age 4.1 (1.7-7.5) years. Four cases were diagnosed with SBI, 41 viral infection (VI), 33 no proven infection (NPI) and 1 bacterial-viral coinfection (the latter excluded from the subanalyses). IL-6 was significantly higher in patients with SBI than in patients with VI or NPI (163 vs 0.7 vs 0.7 pg/ml, p < 0.001), and undetectable in all controls. The rest of the cytokines analyzed did not show any significant difference. The optimal cut-off value of IL-6 for the diagnosis of SBI was 125 pg/mL, with high PPV and NPV (PPV of 100% for a prevalence rate of 5, 10 and 15% and NPV of 98.7%, 97.3% and 95.8% for those prevalences rates, respectively). CONCLUSION: We found that IL-6 (with a cut-off value of 125 pg/ml) was an optimal marker for SBI in this cohort of febrile SCD children, with high PPV and NPV. Therefore, given its rapid elevation, IL-6 may be useful to early discriminate SCD children at risk of SBI, in order to guide their management.

Topics & Concepts

MedicineAsymptomaticInternal medicineProinflammatory cytokineGastroenterologyCoinfectionEtiologyProspective cohort studyDiseaseCase-control studyImmunologyInflammationHuman immunodeficiency virus (HIV)Hemoglobinopathies and Related DisordersBlood groups and transfusionHematological disorders and diagnostics
Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study | Litcius